| An updated review of the diagnostic methods in delayed drug hypersensitivity A Copaescu, A Gibson, Y Li, JA Trubiano, EJ Phillips Frontiers in pharmacology 11, 573573, 2021 | 55 | 2021 |
| New genetic predictors for abacavir tolerance in HLA-B* 57: 01 positive individuals R Pavlos, P Deshpande, A Chopra, S Leary, K Strautins, D Nolan, ... Human immunology 81 (6), 300-304, 2020 | 24 | 2020 |
| Genomic risk factors driving immune-mediated delayed drug hypersensitivity reactions Y Li, P Deshpande, RJ Hertzman, AM Palubinsky, A Gibson, EJ Phillips Frontiers in Genetics 12, 641905, 2021 | 23 | 2021 |
| Visual genomics analysis studio as a tool to analyze multiomic data RJ Hertzman, P Deshpande, S Leary, Y Li, R Ram, A Chopra, D Cooper, ... Frontiers in genetics 12, 642012, 2021 | 16 | 2021 |
| A low‐cost, sensitive and specific PCR‐based tool for rapid clinical detection of HLA‐B*35 alleles associated with delayed drug hypersensitivity reactions Y Li, P Deshpande, A Chopra, L Choo, A Gibson, EJ Phillips Hla 100 (6), 610-616, 2022 | | 2022 |
| Single-cell multi-omic approaches define common molecular and cellular signals of dominant antigen-driven cells at the site of drug-induced Stevens Johnson Syndrome and Toxic … A Gibson, Y Li, M Thorne, R Ram, A Palubinsky, P Choshi, M Porter, ... Journal of Allergy and Clinical Immunology 149 (2), AB181, 2022 | | 2022 |
| An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity. Front. Pharmacol. 11: 573573. doi: 10.3389/fphar. 2020.573573 A Copaescu, A Gibson, Y Li, JA Trubiano, EJ Phillips Frontiers in Pharmacology| www. frontiersin. org 11, 2021 | | 2021 |
